Type 2 diabetes mellitus is more commonly well controlled in younger men compared to older men

References

• Duman TT, Aktas G, Atak BM. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19:1602–1606.
   PubMed Web of Science ®Google Scholar
• Atak B, Aktas G, Duman TT, et al. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 2019;65:38–42.
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316.
   PubMed Web of Science ®Google Scholar
• Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. (London, England) 2004;363:157–163.
   PubMed Web of Science ®Google Scholar
• Basat S, Sivritepe R, Ortaboz D, et al. The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus. Aging Male. 2018;21:111–115.
   PubMed Web of Science ®Google Scholar
• Panach-Navarrete J, Martinez-Jabaloyas JM. The influence of comorbidities on the aging males’ symptoms scale in patients with erectile dysfunction. Aging Male. 2017;20:146–152.
   PubMed Web of Science ®Google Scholar
• Kuk JL, Saunders TJ, Davidson LE, et al. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339–348.
   PubMed Web of Science ®Google Scholar
• Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr. 2010;91:1123S–1127s.
   PubMed Web of Science ®Google Scholar
• Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of β-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539–543.
   PubMed Web of Science ®Google Scholar
• Liu HH, Li JJ. Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev. 2015;19:43–52.
   PubMed Web of Science ®Google Scholar
• Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984–1994. Circulation 1997;96:37–43.
   PubMed Web of Science ®Google Scholar
• Walter M. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1244–1250.
   PubMed Web of Science ®Google Scholar
• Roden M. Non-invasive studies of glycogen metabolism in human skeletal muscle using nuclear magnetic resonance spectroscopy. Curr Opin Clin Nutr Metab Care. 2001;4:261–266.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Romagnoli C, Pampaloni B, Brandi ML. Muscle endocrinology and its relation with nutrition. Aging Clin Exp Res. 2019. DOI:10.1007/s40520-019-01188-5
   PubMed Web of Science ®Google Scholar
• Allen TL, Whitham M, Febbraio MA. IL-6 muscles in on the gut and pancreas to enhance insulin secretion. Cell Metab. 2012;15:8–9.
   PubMed Web of Science ®Google Scholar
• Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011;93 Suppl 1:S52–S59.
   PubMed Web of Science ®Google Scholar
• Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–450.
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819–829.
   PubMed Web of Science ®Google Scholar
• Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66:904–910.
   PubMed Web of Science ®Google Scholar
• Mazur A, Westerman R, Werdecker A, et al. Testosterone and type 2 diabetes in men. Aging Male. 2014;17:18–24.
   PubMed Web of Science ®Google Scholar
• Saad F, Yassin A, Almehmadi Y, et al. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus: a series of case reports. Aging Male. 2015;18:164–168.
   PubMed Web of Science ®Google Scholar
• Morgunov LY, Denisova IA, Rozhkova TI, et al. Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus. Aging Male. 2018:1–10. DOI:10.1080/13685538.2018.1487932
   PubMed Web of Science ®Google Scholar
• Khripun I, Vorobyev S, Belousov I, et al. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. Aging Male. 2018:1–9. DOI:10.1080/13685538.2018.1506918
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Traish A, Haider KS, Doros G, et al. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Hormone Mol Biol Clin Investig. 2017;30. DOI:10.1515/hmbci-2017-0015
   PubMed Web of Science ®Google Scholar
• Yassin A, Haider A, Haider KS, et al. Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a Registry Study. Diabetes Care 2019;42:1104–1111.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Piątkiewicz P. The prevalence of prediabetes in population of Polish men with late-onset hypogonadism. Aging Male. 2014;17:141–146.
   PubMed Web of Science ®Google Scholar
• Yanase T, Yanagita I, Muta K, et al. Frailty in elderly diabetes patients. Endocr J. 2017;65:1–11.
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–1299.
   PubMed Web of Science ®Google Scholar
• Mauras N, Hayes V, Welch S, et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab. 1998;83:1886–1892.
   PubMed Web of Science ®Google Scholar
• Tenover JL. Testosterone and the aging male. J Androl. 1997;18:103–106.
   PubMed Web of Science ®Google Scholar
• Fang F, Xiao H, Li C, et al. Fasting glucose level is associated with nocturnal hypoglycemia in elderly male patients with type 2 diabetes. Aging Male. 2013;16:132–136.
   PubMed Web of Science ®Google Scholar